Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.

Sporadic inclusion body myositis (sIBM) is the most common myopathy presenting over the age of 40 years but its prevalence varies considerably in different populations. Genetic factors play a part in the pathogenesis of sIBM and in Caucasians susceptibility has been linked to the HLA-DR3 allele and the 8.1 MHC ancestral haplotype (AH) which is also associated with other autoimmune diseases. The variable prevalence of sIBM in different populations may be related to differences in the population frequency of this haplotype. Our recent observations indicate that the clinical phenotype at presentation is also quite variable and that the influence of the MHC is more complex than previously appreciated with HLA alleles also having modifying effects on the age-at-onset, severity and rate of progression of the disease. Recent recombinant mapping studies of polymorphisms in the Class II/III regions of the MHC by our group have further refined the susceptibility region and have identified a number of candidate genes warranting further investigation. The significance of these findings for the pathogenesis of the disease is discussed.

[1]  W. Engel,et al.  Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer’s and Parkinson’s disease brains , 2008, Acta Neuropathologica.

[2]  Ian James,et al.  Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype , 2009, Neuromuscular Disorders.

[3]  C. Witt,et al.  Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex , 1999, Immunogenetics.

[4]  F. Mastaglia,et al.  Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3. , 2004, Tissue antigens.

[5]  Allan D. Kirk,et al.  Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis , 2009, Brain : a journal of neurology.

[6]  F L Mastaglia,et al.  Sporadic inclusion body myositis: Phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[7]  M. Dalakas,et al.  Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategies , 2006, Nature Clinical Practice Neurology.

[8]  M. Dalakas,et al.  Interrelation of inflammation and APP in sIBM: IL-1β induces accumulation of β-amyloid in skeletal muscle , 2008, Brain : a journal of neurology.

[9]  F. Christiansen,et al.  The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases , 1999, Immunological reviews.

[10]  F. Mastaglia,et al.  Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52.1 , 2006, Neuromuscular Disorders.

[11]  R. Lovelace,et al.  Inclusion body myositis mimicking motor neuron disease. , 2001, Archives of neurology.

[12]  S. Greenberg Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications , 2007, Neurology.

[13]  Timothy Day,et al.  Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis , 2008, Journal of Clinical Neuroscience.

[14]  F L Mastaglia,et al.  Patterns of muscle involvement in inclusion body myositis: Clinical and magnetic resonance imaging study , 2001, Muscle & nerve.

[15]  S. Khadilkar,et al.  Study of idiopathic inflammatory myopathies with special reference to borderland between idiopathic inflammatory myopathies and muscular dystrophies. , 2008, Neurology India.

[16]  F L Mastaglia,et al.  Genetics of inclusion‐body myositis , 2007, Muscle & nerve.

[17]  M. Carrington,et al.  Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 Allelic Profiles and Motifs Define Clinicopathologic Groups in Caucasians , 2005, Medicine.

[18]  S. Dimauro,et al.  Inclusion body myositis and myopathies , 1995, Annals of neurology.

[19]  Susan Walters,et al.  Familial inclusion body myositis in a mother and son with different ancestral MHC haplotypes , 2006, Neuromuscular Disorders.

[20]  F. Mastaglia,et al.  Sporadic inclusion body myositis: a continuing puzzle , 2008, Neuromuscular Disorders.